Ames, IA, United States of America

Sujata Senapati

This inventor holds 1 USPTO granted patent. Top assignee: Iowa State University Research Foundation Inc.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Sujata Senapati. Retrieved from https://idiyas.com/inventor/sujata-senapati

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Sujata Senapati’s Innovation in Antibody Production

Introduction

Sujata Senapati is an inventor associated with Ames, Iowa. Her work includes an invention designed to make antibody production more rapid and efficient.

Latest Patents

Senapati is associated with 1 patent, titled “Nanoscale Polymeric Micellar Scaffolds for Rapid and Efficient Antibody Production.” The patent describes compositions and methods for producing antibodies in vitro and in vivo to neutralize antigens. It focuses on scaffolds made from amphiphilic multiblock copolymers that form micelles and support antigen-specific B-cell receptor crosslinking. The approach is intended to produce antibodies more efficiently than other monoclonal antibody production methods.

Career Highlights

Senapati’s patent is associated with the Iowa State University Research Foundation Inc. It reflects research into polymeric scaffolds and methods for antibody production.

Collaborations

Her listed coworkers include Surya Mallapragada and Michael Wannemuehler.

Conclusion

Sujata Senapati’s patented work explores nanoscale polymeric scaffolds as a way to improve the speed and efficiency of antigen-specific antibody production.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…